1. Heat Shock Proteins in Triple-Negative Breast Cancer (TNBC) Treatment
   Punit Kaur et al, 2015 CrossRef
2. High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients
   Muhammad Usman Rashid et al, 2016, BMC Cancer CrossRef
3. Lymph node status as a prognostic factor in BRCA-positive breast cancer
   Jeeyeon Lee et al, 2017, Journal of Surgical Research CrossRef
4. Comparison of clinical features and oncologic outcomes between familial (non-hereditary) and hereditary breast cancer in Korean female patients
   Chan Sub Park et al, 2020, Asian Journal of Surgery CrossRef
5. PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance.
   Maddison Rose et al, 2020, Front Cell Dev Biol CrossRef
6. The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database
   Maiko Okano et al, 2020, J Hum Genet CrossRef
7. Breast cancer in global health: beyond diversity and inequality
   Lin Liu et al, 2020 CrossRef
8. Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine
   Anastasiia Samusieva et al, 2022, Breast Cancer Res Treat CrossRef
9. PARP1 proximity proteomics reveals interaction partners at stressed replication forks
   Thorsten Mosler et al, 2022 CrossRef
10. Comparative analysis of the effectiveness of neoadjuvant systemic therapy and primary surgical treatment of patients with BRCA-associated triple-negative T1 breast cancer
    Diana A. Enaldieva et al, 2023, HERALD of North-Western State Medical University named after I.I. Mechnikov CrossRef
11. The role of platinum-based antineoplastic drugs and their impact on complete pathological response and prognosis in patients with BRCA-associated triple-negative breast cancer after neoadjuvant treatment: a single institution experience
    D. A. Enaldieva et al, 2023, Opuholi ženskoj reproduktivnoj sistemy CrossRef
12. Efficacy of Cold Atmospheric Plasma vs. Chemotherapy in Triple-Negative Breast Cancer: A Systematic Review
    Catarina Almeida-Ferreira et al, 2024, IJMS CrossRef
13. Mitomycin C in the treatment of early triple-negative locally advanced BRCA-associated breast cancer
    D. A. Enaldieva et al, 2024, Medicinskij alfavit CrossRef
14. Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to Paclitaxel.
    Karam Soliman, 0 CrossRef
15. The Integration of Radiotherapy with Systemic Therapy in Advanced Triple-Negative Breast Cancer
    Fang Yang, 2024, Critical Reviews in Oncology/Hematology CrossRef